PROSPECTUS SUPPLEMENT
(To prospectus dated February 27, 2019)
45,000,000 Shares
Common Stock
We have entered into an equity distribution agreement with JMP Securities LLC relating to shares of common stock, par value $0.01 per share, or our common stock, offered by this prospectus supplement. In accordance with the terms of the equity distribution agreement, we may offer and sell up to 45,000,000 shares of our common stock from time to time through JMP Securities LLC.
Our common stock is listed on the New York Stock Exchange, or the NYSE, under the symbol “IVR.” The last reported sale price of our common stock on the NYSE on November 27, 2020 was $3.47 per share.
Sales of the shares to which this prospectus supplement and the accompanying prospectus relate, if any, will be made by means of ordinary brokers’ transactions on the NYSE or otherwise at market prices prevailing at the time of sale (which may be deemed to be “at the market” offerings as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended, or the Securities Act) or negotiated transactions, or as otherwise agreed with JMP Securities LLC, including in block transactions or any other method permitted by law. The offering of common stock pursuant to the equity distribution agreement will terminate upon the earlier of (1) the sale of all the shares of our common stock subject to the equity distribution agreement, and (2) the termination of the equity distribution agreement, pursuant to its terms, by either the sales agent or us. JMP Securities LLC will make all sales using commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreed terms between JMP Securities LLC and us.
Under the terms of the equity distribution agreement, we also may sell shares to JMP Securities LLC, as principal for its own account, at a price per share to be agreed upon at the time of sale. If we sell shares to JMP Securities LLC acting as principal, we will enter into a separate terms agreement setting forth the terms of such transaction, and we will describe the terms agreement in a separate prospectus supplement or pricing supplement.
JMP Securities LLC will be entitled to compensation of up to 2.0% of the gross proceeds from the sale of the shares of our common stock sold through it under the equity distribution agreement, as further described herein under the caption “Plan of Distribution.” In connection with the sale of shares of our common stock on our behalf, JMP Securities LLC may be deemed to be an “underwriter” within the meaning of the Securities Act and the compensation of JMP Securities LLC may be deemed to be underwriting commissions or discounts.
To assist us in maintaining our qualification as a real estate investment trust, or REIT, for federal income tax purposes, among other purposes, no person may own (or be treated as owning under applicable attribution rules) more than 9.8% by value or number of shares, whichever is more restrictive, of our outstanding shares of capital stock or common stock, unless our board of directors waives this limitation. See “Restrictions on Ownership and Transfer” in the accompanying prospectus.
Investing in our common stock involves a high degree of risk. Before buying any shares, you should read the discussion of material risks of investing in our common stock under the caption “Supplemental Risk Factors” beginning on page S-6 of this prospectus supplement, in Item 1A of Part I beginning on page 11 of our Annual Report on Form 10-K for the year ended December 31, 2019, under the heading “Item 1A. Risk Factors” beginning on page 66 of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, and risks we disclose in future filings from time to time with the Securities and Exchange Commission, or the SEC.
Neither the SEC, any state securities commission, nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus supplement and the accompanying prospectus to which it relates are truthful and complete. Any representation to the contrary is a criminal offense.
JMP Securities
The date of this prospectus supplement is November 30, 2020.